On the stock market since 1999, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth (4% a year). Red columns mark years that ended in a loss.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
The stock trades 27% below its peak. The market has trimmed its expectations for the company.
Sales run at $26.8M a year. A small number, but proof the product has real buyers.
It pays out $0.86 per share each year — regular cash for whoever holds the stock.
A loss of $23.1M against $26.8M in annual sales. And on top of that, sales fell from the year before.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 3/10.
Costs swallow the gains that sales growth brings in. Council score: 4/10.
On our five-subject report card, NAN sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: NAN is a high-risk stock — not yet profitable, and its future rides on its product catching on.